dc.contributor.author |
Senanayake, M. P. |
|
dc.contributor.author |
Mettananda, D. S. G. |
|
dc.contributor.author |
Vidyatilake, Sudharma |
|
dc.date.accessioned |
2021-09-23T05:29:17Z |
|
dc.date.available |
2021-09-23T05:29:17Z |
|
dc.date.issued |
2011 |
|
dc.identifier.citation |
Senanayake, M. P., Mettananda, D. S. G., & Vidyatilake, S. (2011). Profound thrombocytopenia and generalized hyperpigmentation following pyrimethamine use. Sri Lanka Journal of Child Health, 40, 134-135. |
en_US |
dc.identifier.uri |
http://archive.cmb.ac.lk:8080/xmlui/handle/70130/6043 |
|
dc.description.abstract |
Pyrimethamine is an effective anti-parasitic
medication with a narrow therapeutic index. We
report a child with toxoplasmosis who developed
hyperpigmentation and profound thrombocytopenia
during a course of treatment with pyrimethamine.
These two unusual complications occurred in
addition to folate deficiency and megaloblastic
anaemia which are recognized adverse effects of this
medication. |
|
dc.description.abstract |
Pyrimethamine is an effective anti-parasitic
medication with a narrow therapeutic index. We
report a child with toxoplasmosis who developed
hyperpigmentation and profound thrombocytopenia
during a course of treatment with pyrimethamine.
These two unusual complications occurred in
addition to folate deficiency and megaloblastic
anaemia which are recognized adverse effects of this
medication |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Sri Lanka college of pediatricians |
en_US |
dc.subject |
Pyrimethamine |
en_US |
dc.subject |
profound thrombocytopenia |
en_US |
dc.subject |
hyperpigmentation |
en_US |
dc.title |
Profound thrombocytopenia and generalized hyperpigmentation following pyrimethamine use |
en_US |
dc.type |
Article |
en_US |